
About Arkgen Enterprises Private Limited
Data last updated:
Arkgen Enterprises Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 03 November 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2005PTC037593. Its GSTIN is 29AACCV1339C1ZJ (Karnataka).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.45 Cr. It was formerly known as Viziphar Biosciences Private Limited. It is led by directors Padiyath Mohammed Akbarali and Hathika Akbarali.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹92.67 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹9.89 Lakh (net margin 10.7%) and EBITDA of ₹11.34 Lakh (EBITDA margin 12.2%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 8% over five years.
The company has 1 deal on record (1 acquisition); the latest was in August 2013.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vizipharbio.com.
Company details
Contact details
Arkgen Enterprises Private Limited's registered office is in Bangalore, Karnataka. Its website is vizipharbio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot #488B Flat # 303 – 304 Vitc Model Export Bhavan 14th Crs IV Phase II Stage Peenya Indu., Area, Bangalore, Karnataka, India – 560058
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Arkgen Enterprises Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Arkgen Enterprises is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Arkgen Enterprises Private Limited, buy the company report.
Financials of Arkgen Enterprises Private Limited
FY 2025 filings availableArkgen Enterprises Private Limited reported revenue of ₹92.67 Lakh (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 6% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.89 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.2% | ||||
| Net Profit Margin | 10.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Arkgen Enterprises Private Limited, buy the company report.
Board of directors of Arkgen Enterprises Private Limited
Arkgen Enterprises has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Padiyath Mohammed Akbarali Also directs: Arkgen Pharma Private Limited | Director | 19 May 2016 | 10 Years 6 Months | Current |
| Hathika Akbarali Also directs: Arkgen Pharma Private Limited | Director | 19 May 2016 | 10 Years 6 Months | Current |
Auditor
Arkgen Enterprises Private Limited is audited by Raviprasad Thantry K R for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Raviprasad Thantry K R | FY 2022 | 211391 |
Shareholding
The shareholding of Arkgen Enterprises Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Arkgen Enterprises Private Limited, buy the company report.
Deals & funding
Arkgen Enterprises Private Limited has 1 deal on record (1 acquisition); the latest was in August 2013.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2013 | Acquisition | ₹46 Lakh | Buyer: Laurus Labs Limited Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Arkgen Enterprises Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arkgen Enterprises Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Arkgen Enterprises has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AACCV1339C1ZJ | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Arkgen Enterprises Private Limited, buy the company report.
Recent activity
Arkgen Enterprises Private Limited has 9 board changes on record since 2006: 3 appointments and 6 cessations. The latest: Sreenivasa Rao Damarla ceased to be Whole-Time Director on 29 Aug 2016.
Frequently asked questions
Arkgen Enterprises is an active private limited company based in Bangalore, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 03 November 2005 (21+ years old) and is registered under CIN U73100KA2005PTC037593.
Arkgen Enterprises has 2 current directors:
- Padiyath Mohammed Akbarali - Director
- Hathika Akbarali - Director
The latest financial statements of Arkgen Enterprises on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Arkgen Enterprises is 29AACCV1339C1ZJ, registered in Karnataka.
The CIN (Corporate Identification Number) of Arkgen Enterprises is U73100KA2005PTC037593. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arkgen Enterprises was incorporated on 03 November 2005, making it 21+ years old. It is registered with the Registrar of Companies, Bangalore.
Arkgen Enterprises has 1 deal on record (1 acquisition); the latest was in August 2013.
Sreenivasa Rao Damarla ceased to be Whole-Time Director on 29 Aug 2016. Chandrakanth Chereddi ceased to be Additional Director on 19 May 2016. Hathika Akbarali was appointed as Director on 19 May 2016. Arkgen Enterprises has 9 board changes on record in total.
Arkgen Enterprises can be reached through the website vizipharbio.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Arkgen Enterprises is at Plot #488B Flat # 303 – 304 Vitc Model Export Bhavan 14th Crs IV Phase II Stage Peenya Indu., Area, Bangalore, Karnataka, India – 560058.

